This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
WWW: http://www.msd-uk.com
Medical Information e-mail: medicalinformationuk@merck.com
Stock Availability: Call MSD customer services on 01992 452094

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 15/08/2012
PIL Cosopt Ophthalmic Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2012 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 25/05/2012 and displayed until 15/08/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 17/06/2010 and displayed until 25/05/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 16/02/2010 and displayed until 17/06/2010
Reasons for adding or updating:
  • Change to storage instructions
Updated on 03/07/2009 and displayed until 16/02/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Extra statutory information
Updated on 29/06/2009 and displayed until 03/07/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 15/06/2009 and displayed until 29/06/2009
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information
Updated on 13/08/2008 and displayed until 15/06/2009
Reasons for adding or updating:
  • Change to drug interactions
Updated on 25/05/2007 and displayed until 13/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/02/2004 and displayed until 25/05/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 18/02/2003 and displayed until 05/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 25/07/2002 and displayed until 18/02/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 31/10/2001 and displayed until 25/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 18/07/2001 and displayed until 31/10/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 17/08/2000 and displayed until 18/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics